National Bank Q3 2026 slides: strong growth amid capital concerns

National Bank reported Q3 2026 adjusted EPS of $3.39 (+26% YoY) and revenue of $4.053B (+18% YoY), beating analyst EPS of $3.18 by 6.6%, but the stock fell 5.15% to $210.45. The key negative driver was a delay in Canadian Western Bank (CWB) AIRB conversion, pushing expected CET1 capital benefit toward the lower end of 35–55bps and shifting materialization to late 2027 (vs earlier expectations), despite realized cost synergies of $238M and annualized synergies of $277M. Credit quality stayed within guidance (PCL on impaired loans 28bps; CET1 at 13.51%), but investors appeared concerned about slower capital optimization and some margin/expense pressure.

Analysis

The selloff is not about the quarter’s earnings power; it is about the market pricing less near-term optionality from capital. In Canadian banks, the multiple is often driven by how quickly excess CET1 can be converted into buybacks or M&A capacity, so pushing the capital benefit into late 2027 creates a 4-6 quarter overhang even if underlying profitability stays strong. That makes the tape more sensitive to capital-release timelines than to modest beats on EPS or ROE.

Second-order, the main loser is not the franchise but the “integration alpha” story: any bank acquisition pitched on fast regulatory capital accretion will now be discounted more heavily. Relative winners are peers with cleaner, more predictable capital return stories and less execution risk in their own integrations; they should attract incremental capital if investors rotate toward certainty over growth. The fact that credit and deposits are still stable means this is not a balance-sheet stress signal, so the read-through to the broader Canadian bank complex should be modest unless a few more franchises start missing on CET1 or NIM.

The key catalyst window is 1-3 months: Q4 capital refinement, buyback authorization timing, and whether management can keep CET1 comfortably above ~13.3%-13.5% while continuing repurchases. Contrarian view: the market may be over-penalizing a timing shift that does not materially change intrinsic value; if share count keeps falling and synergies stay on track, the 2027 capital benefit can still support a re-rating later. Falsifiers are simple: another 5-10 bps of NIM compression, a pause in buybacks, or CET1 drifting below management’s implied path.

Key Decisions for Investors

• For tactical accounts, wait 48-72 hours before fading the selloff in NBKCF; if the stock holds above the post-earnings gap and management reiterates the 2026 Q4 CET1 uplift, initiate a 1-3 month long with a stop on a close below the recent reaction low. Risk/reward is acceptable only if the market stabilizes the capital story.
• Relative-value pair: long RY or TD vs short NBKCF over the next 1-3 months if you want to own the cleaner capital-return narrative and avoid execution risk from delayed regulatory benefits. This should work best if Canadian bank investors keep paying up for certainty over integration alpha.
• Set an alert on NBKCF CET1 <13.3% or any pause in buybacks/NCIB authorization; if either occurs, the thesis shifts from 'timing issue' to 'structural capital drag,' and the name becomes a short rather than a buy-the-dip.
• Do not express this as a broad bank short. The better hedge for a Canada-bank book is sector beta reduction, because the underlying credit picture is still benign and the negative surprise is idiosyncratic timing rather than deteriorating asset quality.